TSX:OGIPharmaceuticals
Organigram Global Q2 2026 Margins Slip Back Into Loss Challenging Turnaround Narrative
Organigram Global Q2 2026 Earnings: Margins Back Under Pressure
Organigram Global (TSX:OGI) reported Q2 2026 revenue of C$59.8 million with a basic EPS loss of C$0.007, as net income excluding extra items came in at a loss of C$0.9 million for the quarter. The company has seen quarterly revenue move from C$65.6 million and basic EPS of C$0.329 in Q2 2025 to C$59.8 million and basic EPS of C$0.007 in Q2 2026. The latest trailing twelve month figures sit at C$274.2 million of revenue and a...